Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone
This study is currently recruiting participants.
Study NCT00680992   Information provided by Amgen
First Received: May 15, 2008   Last Updated: October 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
GCT
Giant Cell Tumor of Bone
Additional conditions recognized in this trial
Bone Neoplasms
Giant Cell Tumors
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Interventions listed in this trial
Denosumab
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services